Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1979 Mar-Apr;52(2):159–167.

The etiology of chronic active hepatitis in Korea.

A M Prince, R K Gershon
PMCID: PMC2595445  PMID: 377825

Abstract

In a study of apparently normal, healthy Korean Army recruits performed in 1962, we found that 42 of 1,906 screened subjects had elevations of their serum glutamic pyruvate transaminase. Liver biopsies were obtained from 32 of these subjects and 9 of these had a "novel" antigen present, which reacted specifically with a convalescent serum from a case of serum hepatitis. We have recently tested frozen serum obtained from 8/9 of these cases and found that all 8 had HBsAg in their serum which, in some cases, persisted for at least three months. We reviewed the histological specimens from the original 32 cases using newly defined criteria: 18 were diagnosed as chronic active hepatitis and the 8 HbsAg positive cases with the "novel" antigen were in this group. In four of these cases the lesion appeared to progress to cirrhosis during a 3--4 month follow-up period. Since none of the cases had a prior history of hepatitis and no symptoms developed during the follow-up period, our findings emphasize the significance of chronic hepatitis B virus carrier state in the etiology of cryptogenic cirrhosis.

Full text

PDF
159

Images in this article

160-1PLATE 1
on p.160-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  2. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  3. Brzosko W. J., Madaliński K., Krawczyński K., Nowoslawski A. Duality of hepatitis B antigen and its antibody. I. Immunofluorescence studies. J Infect Dis. 1973 Apr;127(4):424–428. doi: 10.1093/infdis/127.4.424. [DOI] [PubMed] [Google Scholar]
  4. CHUNG W. K., MOON S. K., GERSHON R. K., PRINCE A. M., PARK Y. C., CHO Y. S. ANICTERIC HEPATITIS IN KOREA. I. CLINICAL AND LABORATORY STUDIES. Arch Intern Med. 1964 Apr;113:526–534. doi: 10.1001/archinte.1964.00280100034007. [DOI] [PubMed] [Google Scholar]
  5. CHUNG W. K., MOON S. K., GERSHON R. K., PRINCE A. M., POPPER H. ANICTERIC HEPATITIS IN KOREA. II. SERIAL HISTOLOGIC STUDIES. Arch Intern Med. 1964 Apr;113:535–542. doi: 10.1001/archinte.1964.00280100043008. [DOI] [PubMed] [Google Scholar]
  6. Cooper W. C., Gershon R. K., Sun S. C., Fresh J. W. Anicteric viral hepatitis. A clinicopathological follow-up study in Taiwan. N Engl J Med. 1966 Mar 17;274(11):585–595. doi: 10.1056/NEJM196603172741101. [DOI] [PubMed] [Google Scholar]
  7. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  8. Edgington T. S., Ritt D. J. Intrahepatic expression of serum hepatitis virus-associated antigens. J Exp Med. 1971 Oct 1;134(4):871–885. doi: 10.1084/jem.134.4.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerber M. A., Brodin A., Steinberg D., Vernace S., Yang C. P., Paronetto F. Periarteritis nodosa, Australia antigen and lymphatic leukemia. N Engl J Med. 1972 Jan 6;286(1):14–17. doi: 10.1056/NEJM197201062860103. [DOI] [PubMed] [Google Scholar]
  10. Greenberg H. B., Gocke D. J. An analysis of antibody response to Australia antigen in man. J Infect Dis. 1971 Apr;123(4):356–364. doi: 10.1093/infdis/123.4.356. [DOI] [PubMed] [Google Scholar]
  11. Hadziyannis S., Moussouros A., Vissoulis C., Afroudakis A. Cytoplasmic localisation of Australia antigen in the liver. Lancet. 1972 May 6;1(7758):976–979. doi: 10.1016/s0140-6736(72)91153-1. [DOI] [PubMed] [Google Scholar]
  12. Hoofnagle J. H., Gerety R. J., Barker L. F. Antibody to hepatitis-B-virus core in man. Lancet. 1973 Oct 20;2(7834):869–873. doi: 10.1016/s0140-6736(73)92004-7. [DOI] [PubMed] [Google Scholar]
  13. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  15. Millman I., Zavatone V., Gerstley B. J., Blumberg B. S. Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic. Nature. 1969 Apr 12;222(5189):181–184. doi: 10.1038/222181b0. [DOI] [PubMed] [Google Scholar]
  16. Nowoslawski A., Brzosko W. J., Madaliński K., Krawczyński K. Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet. 1970 Mar 7;1(7645):494–498. doi: 10.1016/s0140-6736(70)91580-1. [DOI] [PubMed] [Google Scholar]
  17. PRINCE A. M., FUJI H., GERSHON R. K. IMMUNOHISTOCHEMICAL STUDIES ON THE ETIOLOGY OF ANICTERIC HEPATITIS IN KOREA. Am J Hyg. 1964 May;79:365–381. doi: 10.1093/oxfordjournals.aje.a120391. [DOI] [PubMed] [Google Scholar]
  18. PRINCE A. M., GERSHON R. K. THE USE OF SERUM ENZYME DETERMINATIONS TO DETECT ANICTERIC HEPATITIS. Transfusion. 1965 Mar-Apr;5:120–134. doi: 10.1111/j.1537-2995.1965.tb01147.x. [DOI] [PubMed] [Google Scholar]
  19. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prince A. M., Brotman B., Jass D., Ikram H. Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet. 1973 Jun 16;1(7816):1346–1350. doi: 10.1016/s0140-6736(73)91674-7. [DOI] [PubMed] [Google Scholar]
  21. Prince A. M., Hargrove R. L., Szmuness W., Cherubin C. E., Fontana V. J., Jeffries G. H. Immunologic distinction between infectious and serum hepatitis. N Engl J Med. 1970 Apr 30;282(18):987–991. doi: 10.1056/NEJM197004302821801. [DOI] [PubMed] [Google Scholar]
  22. Prince A. M. Relation of Australia and SH antigens. Lancet. 1968 Aug 24;2(7565):462–463. doi: 10.1016/s0140-6736(68)90512-6. [DOI] [PubMed] [Google Scholar]
  23. Prince A. M. Role of serum hepatitis virus in chronic liver disease. Gastroenterology. 1971 May;60(5):913–921. [PubMed] [Google Scholar]
  24. Szmuness W., Prince A. M., Diebolt G., Leblanc L., Baylet R., Masseyeff R., Linhard J. The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol. 1973 Aug;98(2):104–110. doi: 10.1093/oxfordjournals.aje.a121535. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES